APA (7th ed.) Citation

Geyer, L., Wolf, T., Chenard, M., Cebula, H., Schott, R., Noel, G., . . . Lhermitte, B. (2023). p16 Immunohistochemical Expression as a Surrogate Assessment of CDKN2A Alteration in Gliomas Leading to Prognostic Significances. Cancers, 15(5), 1512. https://doi.org/10.3390/cancers15051512

Chicago Style (17th ed.) Citation

Geyer, Lucas, et al. "P16 Immunohistochemical Expression as a Surrogate Assessment of CDKN2A Alteration in Gliomas Leading to Prognostic Significances." Cancers 15, no. 5 (2023): 1512. https://doi.org/10.3390/cancers15051512.

MLA (9th ed.) Citation

Geyer, Lucas, et al. "P16 Immunohistochemical Expression as a Surrogate Assessment of CDKN2A Alteration in Gliomas Leading to Prognostic Significances." Cancers, vol. 15, no. 5, 2023, p. 1512, https://doi.org/10.3390/cancers15051512.